Motif 275 (n=58)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0C4DFX4 | None | S2663 | ochoa | Snf2 related CREBBP activator protein | None |
A6NFI3 | ZNF316 | S221 | ochoa | Zinc finger protein 316 | May be involved in transcriptional regulation. {ECO:0000250}. |
A6NI72 | NCF1B | S349 | ochoa | Putative neutrophil cytosol factor 1B (NCF-1B) (Putative SH3 and PX domain-containing protein 1B) | May be required for activation of the latent NADPH oxidase (necessary for superoxide production). {ECO:0000250}. |
A8MVU1 | NCF1C | S324 | ochoa | Putative neutrophil cytosol factor 1C (NCF-1C) (Putative SH3 and PX domain-containing protein 1C) | May be required for activation of the latent NADPH oxidase (necessary for superoxide production). {ECO:0000250}. |
O15020 | SPTBN2 | S2359 | ochoa | Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein) | Probably plays an important role in neuronal membrane skeleton. |
P05023 | ATP1A1 | S216 | ochoa | Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-1) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients (PubMed:29499166, PubMed:30388404). Could also be part of an osmosensory signaling pathway that senses body-fluid sodium levels and controls salt intake behavior as well as voluntary water intake to regulate sodium homeostasis (By similarity). {ECO:0000250|UniProtKB:Q8VDN2, ECO:0000269|PubMed:29499166, ECO:0000269|PubMed:30388404}. |
P06732 | CKM | S199 | ochoa | Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (Creatine phosphokinase M-type) (CPK-M) (M-CK) | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. {ECO:0000250|UniProtKB:P00563}. |
P0C1Z6 | TFPT | S180 | ochoa|psp | TCF3 fusion partner (INO80 complex subunit F) (Protein FB1) | Appears to promote apoptosis in a p53/TP53-independent manner.; FUNCTION: Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. |
P0DSO3 | GAGE4 | T40 | ochoa | G antigen 4 (Cancer/testis antigen 4.4) (CT4.4) | Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes. {ECO:0000269|PubMed:7544395}. |
P0DTW1 | GAGE1 | T40 | ochoa | G antigen 1 (GAGE-1) (Antigen MZ2-F) (Cancer/testis antigen 4.1) (CT4.1) | Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes. {ECO:0000269|PubMed:7544395}. |
P12277 | CKB | S199 | ochoa | Creatine kinase B-type (EC 2.7.3.2) (Brain creatine kinase) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type) (CPK-B) | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate) (PubMed:8186255). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa (Probable). Acts as a key regulator of adaptive thermogenesis as part of the futile creatine cycle: localizes to the mitochondria of thermogenic fat cells and acts by mediating phosphorylation of creatine to initiate a futile cycle of creatine phosphorylation and dephosphorylation (By similarity). During the futile creatine cycle, creatine and N-phosphocreatine are in a futile cycle, which dissipates the high energy charge of N-phosphocreatine as heat without performing any mechanical or chemical work (By similarity). {ECO:0000250|UniProtKB:Q04447, ECO:0000269|PubMed:8186255, ECO:0000305}. |
P13637 | ATP1A3 | S206 | ochoa | Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 7.2.2.13) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:33880529}. |
P14598 | NCF1 | S348 | ochoa|psp | Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox) | Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:2547247, PubMed:2550933, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (PubMed:12732142, PubMed:19801500). {ECO:0000269|PubMed:12732142, ECO:0000269|PubMed:19801500, ECO:0000269|PubMed:2547247, ECO:0000269|PubMed:2550933, ECO:0000269|PubMed:38355798}. |
P17540 | CKMT2 | S233 | ochoa | Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK) | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa. |
P20648 | ATP4A | S227 | ochoa | Potassium-transporting ATPase alpha chain 1 (EC 7.2.2.19) (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump) | The catalytic subunit of the gastric H(+)/K(+) ATPase pump which transports H(+) ions in exchange for K(+) ions across the apical membrane of parietal cells. Uses ATP as an energy source to pump H(+) ions to the gastric lumen while transporting K(+) ion from the lumen into the cell (By similarity). Remarkably generates a million-fold proton gradient across the gastric parietal cell membrane, acidifying the gastric juice down to pH 1 (By similarity). Within a transport cycle, the transfer of a H(+) ion across the membrane is coupled to ATP hydrolysis and is associated with a transient phosphorylation that shifts the pump conformation from inward-facing (E1) to outward-facing state (E2). The release of the H(+) ion in the stomach lumen is followed by binding of K(+) ion converting the pump conformation back to the E1 state (By similarity). {ECO:0000250|UniProtKB:P09626, ECO:0000250|UniProtKB:P19156, ECO:0000250|UniProtKB:Q64436}. |
P22415 | USF1 | S186 | psp | Upstream stimulatory factor 1 (Class B basic helix-loop-helix protein 11) (bHLHb11) (Major late transcription factor 1) | Transcription factor that binds to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3') that is found in a variety of viral and cellular promoters. |
P25100 | ADRA1D | T477 | psp | Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a) | This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium. |
P35520 | CBS | S32 | ochoa | Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase) | Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine (PubMed:20506325, PubMed:23974653, PubMed:23981774). Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (By similarity). {ECO:0000250|UniProtKB:P32232, ECO:0000269|PubMed:20506325, ECO:0000269|PubMed:23974653, ECO:0000269|PubMed:23981774}. |
P38936 | CDKN1A | S130 | ochoa|psp | Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21) | Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed:9106657). Involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. Also involved in p53-independent DNA damage-induced G2 arrest mediated by CREB3L1 in astrocytes and osteoblasts (By similarity). Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex. Inhibits DNA synthesis by DNA polymerase delta by competing with POLD3 for PCNA binding (PubMed:11595739). Negatively regulates the CDK4- and CDK6-driven phosphorylation of RB1 in keratinocytes, thereby resulting in the release of E2F1 and subsequent transcription of E2F1-driven G1/S phase promoting genes (By similarity). {ECO:0000250|UniProtKB:P39689, ECO:0000269|PubMed:11595739, ECO:0000269|PubMed:8242751, ECO:0000269|PubMed:9106657}. |
P42695 | NCAPD3 | S1329 | ochoa | Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3) | Regulatory subunit of the condensin-2 complex, a complex which establishes mitotic chromosome architecture and is involved in physical rigidity of the chromatid axis (PubMed:14532007). May promote the resolution of double-strand DNA catenanes (intertwines) between sister chromatids. Condensin-mediated compaction likely increases tension in catenated sister chromatids, providing directionality for type II topoisomerase-mediated strand exchanges toward chromatid decatenation. Specifically required for decatenation of centromeric ultrafine DNA bridges during anaphase. Early in neurogenesis, may play an essential role to ensure accurate mitotic chromosome condensation in neuron stem cells, ultimately affecting neuron pool and cortex size (PubMed:27737959). {ECO:0000269|PubMed:14532007, ECO:0000269|PubMed:27737959}. |
P49069 | CAMLG | S55 | ochoa | Guided entry of tail-anchored proteins factor CAMLG (Calcium signal-modulating cyclophilin ligand) | Required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum (PubMed:23041287, PubMed:24392163, PubMed:27226539). Together with GET1/WRB, acts as a membrane receptor for soluble GET3/TRC40, which recognizes and selectively binds the transmembrane domain of TA proteins in the cytosol (PubMed:23041287, PubMed:24392163, PubMed:27226539). Required for the stability of GET1 (PubMed:32187542). Stimulates calcium signaling in T cells through its involvement in elevation of intracellular calcium (PubMed:7522304). Essential for the survival of peripheral follicular B cells (By similarity). {ECO:0000250|UniProtKB:P49070, ECO:0000269|PubMed:23041287, ECO:0000269|PubMed:24392163, ECO:0000269|PubMed:27226539, ECO:0000269|PubMed:32187542, ECO:0000269|PubMed:7522304}. |
P50993 | ATP1A2 | S214 | ochoa | Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 7.2.2.13) (Sodium pump subunit alpha-2) | This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium, providing the energy for active transport of various nutrients. {ECO:0000269|PubMed:33880529}. |
P56182 | RRP1 | S383 | ochoa | Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein) | Plays a critical role in the generation of 28S rRNA. {ECO:0000269|PubMed:10341208}. |
P67809 | YBX1 | S174 | ochoa|psp | Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor) | DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:10817758, PubMed:11698476, PubMed:14718551, PubMed:18809583, PubMed:31358969, PubMed:8188694). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (PubMed:19561594, PubMed:31358969). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (PubMed:10817758, PubMed:11698476, PubMed:31358969). Component of the CRD-mediated complex that promotes MYC mRNA stability (PubMed:19029303). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (PubMed:27559612, PubMed:29073095). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (PubMed:28341602, PubMed:29073095). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (PubMed:12604611). Binds to TSC22D1 transcripts, thereby inhibiting their translation and negatively regulating TGF-beta-mediated transcription of COL1A2 (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (PubMed:18809583). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (PubMed:18809583, PubMed:8188694). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (PubMed:14718551). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (PubMed:14718551). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (PubMed:19483673). {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:10817758, ECO:0000269|PubMed:11698476, ECO:0000269|PubMed:12604611, ECO:0000269|PubMed:14718551, ECO:0000269|PubMed:18809583, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:19483673, ECO:0000269|PubMed:19561594, ECO:0000269|PubMed:27559612, ECO:0000269|PubMed:28341602, ECO:0000269|PubMed:29073095, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:8188694}. |
Q08050 | FOXM1 | S331 | ochoa|psp | Forkhead box protein M1 (Forkhead-related protein FKHL16) (Hepatocyte nuclear factor 3 forkhead homolog 11) (HFH-11) (HNF-3/fork-head homolog 11) (M-phase phosphoprotein 2) (MPM-2 reactive phosphoprotein 2) (Transcription factor Trident) (Winged-helix factor from INS-1 cells) | Transcription factor regulating the expression of cell cycle genes essential for DNA replication and mitosis (PubMed:19160488, PubMed:20360045). Plays a role in the control of cell proliferation (PubMed:19160488). Also plays a role in DNA break repair, participating in the DNA damage checkpoint response (PubMed:17101782). Promotes transcription of PHB2 (PubMed:33754036). {ECO:0000269|PubMed:17101782, ECO:0000269|PubMed:19160488, ECO:0000269|PubMed:20360045, ECO:0000269|PubMed:33754036}. |
Q13066 | GAGE2B | T39 | ochoa | G antigen 2B/2C (GAGE-2B) (GAGE-2C) (Cancer/testis antigen 4.2) (CT4.2) (G antigen 2C) | Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes. |
Q13069 | GAGE5 | T40 | ochoa | G antigen 5 (GAGE-5) (Cancer/testis antigen 4.5) (CT4.5) | None |
Q13070 | GAGE6 | T40 | ochoa | G antigen 6 (GAGE-6) (Cancer/testis antigen 4.6) (CT4.6) | None |
Q14160 | SCRIB | S504 | ochoa | Protein scribble homolog (Scribble) (hScrib) (Protein LAP4) | Scaffold protein involved in different aspects of polarized cell differentiation regulating epithelial and neuronal morphogenesis and T-cell polarization (PubMed:15182672, PubMed:16344308, PubMed:16965391, PubMed:18641685, PubMed:18716323, PubMed:19041750, PubMed:27380321). Via its interaction with CRTAM, required for the late phase polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG and IL22 production (By similarity). Plays a role in cell directional movement, cell orientation, cell sheet organization and Golgi complex polarization at the cell migration front (By similarity). Promotes epithelial cell layer barrier function via maintaining cell-cell adhesion (By similarity). Most probably functions in the establishment of apico-basal cell polarity (PubMed:16344308, PubMed:19041750). May function in cell proliferation regulating progression from G1 to S phase and as a positive regulator of apoptosis for instance during acinar morphogenesis of the mammary epithelium (PubMed:16965391, PubMed:19041750). May regulate cell invasion via MAPK-mediated cell migration and adhesion (PubMed:18641685, PubMed:18716323). May play a role in exocytosis and in the targeting of synaptic vesicles to synapses (PubMed:15182672). Functions as an activator of Rac GTPase activity (PubMed:15182672). {ECO:0000250|UniProtKB:A0A8P0N4K0, ECO:0000250|UniProtKB:Q80U72, ECO:0000269|PubMed:15182672, ECO:0000269|PubMed:16344308, ECO:0000269|PubMed:16965391, ECO:0000269|PubMed:18641685, ECO:0000269|PubMed:18716323, ECO:0000269|PubMed:19041750, ECO:0000269|PubMed:27380321}. |
Q14676 | MDC1 | S793 | ochoa | Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1) | Histone reader protein required for checkpoint-mediated cell cycle arrest in response to DNA damage within both the S phase and G2/M phases of the cell cycle (PubMed:12475977, PubMed:12499369, PubMed:12551934, PubMed:12607003, PubMed:12607004, PubMed:12607005, PubMed:12611903, PubMed:14695167, PubMed:15201865, PubMed:15377652, PubMed:16049003, PubMed:16377563, PubMed:30898438). Specifically recognizes and binds histone H2AX phosphorylated at 'Ser-139', a marker of DNA damage, serving as a scaffold for the recruitment of DNA repair and signal transduction proteins to discrete foci of DNA damage sites (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:30898438). Also required for downstream events subsequent to the recruitment of these proteins (PubMed:12607005, PubMed:15201865, PubMed:16049003, PubMed:16377563, PubMed:18582474). These include phosphorylation and activation of the ATM, CHEK1 and CHEK2 kinases, and stabilization of TP53/p53 and apoptosis (PubMed:12499369, PubMed:12551934, PubMed:12607004). ATM and CHEK2 may also be activated independently by a parallel pathway mediated by TP53BP1 (PubMed:12499369, PubMed:12551934, PubMed:12607004). Required for chromosomal stability during mitosis by promoting recruitment of TOPBP1 to DNA double strand breaks (DSBs): TOPBP1 forms filamentous assemblies that bridge MDC1 and tether broken chromosomes during mitosis (PubMed:30898438). Required for the repair of DSBs via homologous recombination by promoting recruitment of NBN component of the MRN complex to DSBs (PubMed:18411307, PubMed:18582474, PubMed:18583988, PubMed:18678890). {ECO:0000269|PubMed:12475977, ECO:0000269|PubMed:12499369, ECO:0000269|PubMed:12551934, ECO:0000269|PubMed:12607003, ECO:0000269|PubMed:12607004, ECO:0000269|PubMed:12607005, ECO:0000269|PubMed:12611903, ECO:0000269|PubMed:14695167, ECO:0000269|PubMed:15201865, ECO:0000269|PubMed:15377652, ECO:0000269|PubMed:16049003, ECO:0000269|PubMed:16377563, ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18582474, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:30898438}. |
Q15464 | SHB | S388 | ochoa | SH2 domain-containing adapter protein B | Adapter protein which regulates several signal transduction cascades by linking activated receptors to downstream signaling components. May play a role in angiogenesis by regulating FGFR1, VEGFR2 and PDGFR signaling. May also play a role in T-cell antigen receptor/TCR signaling, interleukin-2 signaling, apoptosis and neuronal cells differentiation by mediating basic-FGF and NGF-induced signaling cascades. May also regulate IRS1 and IRS2 signaling in insulin-producing cells. {ECO:0000269|PubMed:10828022, ECO:0000269|PubMed:10837138, ECO:0000269|PubMed:12084069, ECO:0000269|PubMed:12464388, ECO:0000269|PubMed:12520086, ECO:0000269|PubMed:15026417, ECO:0000269|PubMed:15919073, ECO:0000269|PubMed:8806685, ECO:0000269|PubMed:9484780, ECO:0000269|PubMed:9751119}. |
Q15853 | USF2 | S222 | psp | Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12) (bHLHb12) (FOS-interacting protein) (FIP) (Major late transcription factor 2) (Upstream transcription factor 2) | Transcription factor that binds to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3') that is found in a variety of viral and cellular promoters. |
Q17RS7 | GEN1 | S269 | ochoa | Flap endonuclease GEN homolog 1 (EC 3.1.-.-) | Endonuclease which resolves Holliday junctions (HJs) by the introduction of symmetrically related cuts across the junction point, to produce nicked duplex products in which the nicks can be readily ligated. Four-way DNA intermediates, also known as Holliday junctions, are formed during homologous recombination and DNA repair, and their resolution is necessary for proper chromosome segregation (PubMed:19020614, PubMed:26682650). Cleaves HJs by a nick and counter-nick mechanism involving dual coordinated incisions that lead to the formation of ligatable nicked duplex products. Cleavage of the first strand is rate limiting, while second strand cleavage is rapid. Largely monomeric, dimerizes on the HJ and the first nick occurs upon dimerization at the junction (PubMed:26578604). Efficiently cleaves both single and double HJs contained within large recombination intermediates. Exhibits a weak sequence preference for incision between two G residues that reside in a T-rich region of DNA (PubMed:28049850). Also has endonuclease activity on 5'-flap and replication fork (RF) DNA substrates (PubMed:26578604). {ECO:0000269|PubMed:19020614, ECO:0000269|PubMed:26578604, ECO:0000269|PubMed:26682650, ECO:0000269|PubMed:28049850}. |
Q5T011 | SZT2 | S1825 | ochoa | KICSTOR complex protein SZT2 (Seizure threshold 2 protein homolog) | As part of the KICSTOR complex functions in the amino acid-sensing branch of the TORC1 signaling pathway. Recruits, in an amino acid-independent manner, the GATOR1 complex to the lysosomal membranes and allows its interaction with GATOR2 and the RAG GTPases. Functions upstream of the RAG GTPases and is required to negatively regulate mTORC1 signaling in absence of amino acids. In absence of the KICSTOR complex mTORC1 is constitutively localized to the lysosome and activated. The KICSTOR complex is also probably involved in the regulation of mTORC1 by glucose (PubMed:28199306, PubMed:28199315). May play a role in the cellular response to oxidative stress (By similarity). {ECO:0000250|UniProtKB:A2A9C3, ECO:0000269|PubMed:28199306, ECO:0000269|PubMed:28199315}. |
Q5T6C5 | ATXN7L2 | S213 | ochoa | Ataxin-7-like protein 2 | None |
Q5UE93 | PIK3R6 | S358 | ochoa|psp | Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein) (p84 PIKAP) (p87 PI3K adapter protein) (p87PIKAP) | Regulatory subunit of the PI3K gamma complex. Acts as an adapter to drive activation of PIK3CG by beta-gamma G protein dimers. The PIK3CG:PIK3R6 heterodimer is much less sensitive to beta-gamma G protein dimers than PIK3CG:PIK3R5 and its membrane recruitment and beta-gamma G protein dimer-dependent activation requires HRAS bound to PIK3CG. Recruits of the PI3K gamma complex to a PDE3B:RAPGEF3 signaling complex involved in angiogenesis; signaling seems to involve RRAS. {ECO:0000269|PubMed:21393242}. |
Q6IPM2 | IQCE | S598 | ochoa | IQ domain-containing protein E | Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling (By similarity). Required for proper limb morphogenesis (PubMed:28488682). {ECO:0000250|UniProtKB:Q6PCQ0, ECO:0000269|PubMed:28488682}. |
Q6NT46 | GAGE2A | T39 | ochoa | G antigen 2A (GAGE-2A) | None |
Q6NYC8 | PPP1R18 | S133 | ochoa | Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) | [Isoform 1]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:24434620}.; FUNCTION: [Isoform 4]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:17374523}. |
Q6PJ61 | FBXO46 | S293 | ochoa | F-box only protein 46 (F-box only protein 34-like) | Substrate-recognition component of the SCF(FBXO46) protein ligase complex, which mediates the ubiquitination and degradation of target proteins (PubMed:30171069). In absence of stress, the SCF(FBXO46) complex catalyzes ubiquitination and degradation of MTOR-phosphorylated FBXO31 (PubMed:30171069). {ECO:0000269|PubMed:30171069}. |
Q6UXY8 | TMC5 | S184 | ochoa | Transmembrane channel-like protein 5 | Probable component of an ion channel (Probable). Molecular function hasn't been characterized yet (Probable). {ECO:0000305}. |
Q6ZRS2 | SRCAP | S2840 | ochoa | Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator) | Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}. |
Q765P7 | MTSS2 | Y655 | ochoa | Protein MTSS 2 (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1) (MTSS1-like protein) | Involved in plasma membrane dynamics. Potentiated PDGF-mediated formation of membrane ruffles and lamellipodia in fibroblasts, acting via RAC1 activation (PubMed:14752106). May function in actin bundling (PubMed:14752106). {ECO:0000269|PubMed:14752106}. |
Q76NI1 | KNDC1 | S392 | ochoa | Kinase non-catalytic C-lobe domain-containing protein 1 (KIND domain-containing protein 1) (Cerebral protein 9) (Protein very KIND) (v-KIND) (Ras-GEF domain-containing family member 2) | RAS-Guanine nucleotide exchange factor (GEF) that controls the negative regulation of neuronal dendrite growth by mediating a signaling pathway linking RAS and MAP2 (By similarity). May be involved in cellular senescence (PubMed:24788352). {ECO:0000250|UniProtKB:Q0KK55, ECO:0000269|PubMed:24788352}. |
Q86VQ1 | GLCCI1 | S148 | ochoa | Glucocorticoid-induced transcript 1 protein | None |
Q8IU68 | TMC8 | S683 | ochoa | Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2) | Acts as a regulatory protein involved in the regulation of numerous cellular processes (PubMed:18158319, PubMed:23429285, PubMed:30068544, PubMed:32917726). Together with its homolog TMC6/EVER1, forms a complex with calcium-binding protein CIB1 in lymphocytes and keratynocytes where TMC6 and TMC8 stabilize CIB1 levels and reciprocally (PubMed:30068544, PubMed:32917726). Together with TMC6, also forms a complex with and activates zinc transporter ZNT1 at the ER membrane of keratynocytes, thereby facilitating zinc uptake into the ER (PubMed:18158319). Also inhibits receptor-mediated calcium release from ER stores and calcium activated and volume regulated chloride channels (PubMed:25220380). Down-regulates the activity of transcription factors induced by zinc and cytokines (PubMed:18158319). Also sequesters TRADD which impairs the recruitment of TRAF2 and RIPK1 in the pro-survival complex I and promotes proapoptotic complex II formation, and may therefore be involved in TNF-induced cell death/survival decisions (PubMed:23429285). {ECO:0000269|PubMed:18158319, ECO:0000269|PubMed:23429285, ECO:0000269|PubMed:25220380, ECO:0000269|PubMed:30068544, ECO:0000269|PubMed:32917726}. |
Q8IX07 | ZFPM1 | S84 | ochoa | Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1) | Transcription regulator that plays an essential role in erythroid and megakaryocytic cell differentiation. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA1, GATA2 and GATA3. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. The heterodimer formed with GATA proteins is essential to activate expression of genes such as NFE2, ITGA2B, alpha- and beta-globin, while it represses expression of KLF1. May be involved in regulation of some genes in gonads. May also be involved in cardiac development, in a non-redundant way with ZFPM2/FOG2 (By similarity). {ECO:0000250}. |
Q8IZT6 | ASPM | S225 | ochoa | Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog) | Involved in mitotic spindle regulation and coordination of mitotic processes. The function in regulating microtubule dynamics at spindle poles including spindle orientation, astral microtubule density and poleward microtubule flux seems to depend on the association with the katanin complex formed by KATNA1 and KATNB1. Enhances the microtubule lattice severing activity of KATNA1 by recruiting the katanin complex to microtubules. Can block microtubule minus-end growth and reversely this function can be enhanced by the katanin complex (PubMed:28436967). May have a preferential role in regulating neurogenesis. {ECO:0000269|PubMed:12355089, ECO:0000269|PubMed:15972725, ECO:0000269|PubMed:28436967}. |
Q8N8E2 | ZNF513 | S253 | ochoa | Zinc finger protein 513 | Transcriptional regulator that plays a role in retinal development and maintenance. {ECO:0000269|PubMed:20797688}. |
Q8WZ73 | RFFL | S39 | ochoa | E3 ubiquitin-protein ligase rififylin (EC 2.3.2.27) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin) | E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Mediates 'Lys-48'-linked polyubiquitination of PRR5L and its subsequent proteasomal degradation thereby indirectly regulating cell migration through the mTORC2 complex. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis. Negatively regulates the tumor necrosis factor-mediated signaling pathway through targeting of RIPK1 to ubiquitin-mediated proteasomal degradation. Negatively regulates p53/TP53 through its direct ubiquitination and targeting to proteasomal degradation. Indirectly, may also negatively regulate p53/TP53 through ubiquitination and degradation of SFN. May also play a role in endocytic recycling. {ECO:0000269|PubMed:15069192, ECO:0000269|PubMed:17121812, ECO:0000269|PubMed:18382127, ECO:0000269|PubMed:18450452, ECO:0000269|PubMed:22609986}. |
Q92797 | SYMPK | S510 | ochoa | Symplekin | Scaffold protein that functions as a component of a multimolecular complex involved in histone mRNA 3'-end processing. Specific component of the tight junction (TJ) plaque, but might not be an exclusively junctional component. May have a house-keeping rule. Is involved in pre-mRNA polyadenylation. Enhances SSU72 phosphatase activity. {ECO:0000269|PubMed:16230528, ECO:0000269|PubMed:20861839}. |
Q96G74 | OTUD5 | S165 | ochoa | OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA) | Deubiquitinating enzyme that functions as a negative regulator of the innate immune system (PubMed:17991829, PubMed:22245969, PubMed:23827681, PubMed:33523931). Has peptidase activity towards 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:22245969). Can also cleave 'Lys-11'-linked ubiquitin chains (in vitro) (PubMed:22245969). Acts via TRAF3 deubiquitination and subsequent suppression of type I interferon (IFN) production (PubMed:17991829). Controls neuroectodermal differentiation through cleaving 'Lys-48'-linked ubiquitin chains to counteract degradation of select chromatin regulators such as ARID1A, HDAC2 and HCF1 (PubMed:33523931). Acts as a positive regulator of mTORC1 and mTORC2 signaling following phosphorylation by MTOR: acts by mediating deubiquitination of BTRC, leading to its stability (PubMed:33110214). {ECO:0000269|PubMed:17991829, ECO:0000269|PubMed:22245969, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:33110214, ECO:0000269|PubMed:33523931}. |
Q96KM6 | ZNF512B | S63 | ochoa | Zinc finger protein 512B | Involved in transcriptional regulation by repressing gene expression (PubMed:39460621). Associates with the nucleosome remodeling and histone deacetylase (NuRD) complex, which promotes transcriptional repression by histone deacetylation and nucleosome remodeling (PubMed:39460621). {ECO:0000269|PubMed:39460621}. |
Q9BV73 | CEP250 | S2259 | ochoa | Centrosome-associated protein CEP250 (250 kDa centrosomal protein) (Cep250) (Centrosomal Nek2-associated protein 1) (C-Nap1) (Centrosomal protein 2) | Plays an important role in centrosome cohesion during interphase (PubMed:30404835, PubMed:36282799). Recruits CCDC102B to the proximal ends of centrioles (PubMed:30404835). Maintains centrosome cohesion by forming intercentriolar linkages (PubMed:36282799). Accumulates at the proximal end of each centriole, forming supramolecular assemblies with viscous material properties that promote organelle cohesion (PubMed:36282799). May be involved in ciliogenesis (PubMed:28005958). {ECO:0000269|PubMed:28005958, ECO:0000269|PubMed:30404835, ECO:0000269|PubMed:36282799}. |
Q9UET6 | FTSJ1 | S271 | ochoa | tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1) | Methylates the 2'-O-ribose of nucleotides at positions 32 and 34 of the tRNA anticodon loop of substrate tRNAs (PubMed:25404562, PubMed:26310293, PubMed:32198346, PubMed:32558197, PubMed:33771871, PubMed:36720500). Requisite for faithful cytoplasmic translation (PubMed:32393790). Requires THADA for methylation of the nucleotide at position 32 of the anticodon loop of substrate tRNAs (PubMed:25404562, PubMed:26310293). Requires WDR6 for methylation of the nucleotide at position 34 of the anticodon loop of substrate tRNAs (PubMed:32558197, PubMed:33771871). Promotes translation efficiency of the UUU codon (PubMed:32558197). Plays a role in neurogenesis (PubMed:36720500). Required for expression of genes involved in neurogenesis, mitochondrial translation and energy generation, and lipid biosynthesis (PubMed:33771871, PubMed:36720500). Requisite for RNA-mediated gene silencing (PubMed:36720500). May modify position 32 in tRNA(Arg(ACG)), tRNA(Arg(CCG)), tRNA(Arg(UCG)), tRNA(Cys(GCA)), tRNA(Cys(ACA)), tRNA(Gln(CUG)), tRNA(Gln(UUG)), tRNA(Gly(CCC)), tRNA(Leu(CAG))/tRNA(Leu(CAA)), tRNA(Leu(A/IAG)), tRNA(Leu(UAG)), tRNA(Phe(GAA)), tRNA(Pro(AGG))/tRNA(Pro(CGG))/tRNA(Pro(UGG)) and tRNA(Trp(CCA)), and position 34 in tRNA(Phe(GAA)), tRNA(Leu(CAA)), tRNA(Sec(UCA)), and tRNA(Trp(CCA)) (PubMed:26310293, PubMed:32198346, PubMed:32558197, PubMed:33771871, PubMed:36720500). {ECO:0000269|PubMed:25404562, ECO:0000269|PubMed:26310293, ECO:0000269|PubMed:32198346, ECO:0000269|PubMed:32393790, ECO:0000269|PubMed:32558197, ECO:0000269|PubMed:33771871, ECO:0000269|PubMed:36720500}. |
Q9UEU5 | GAGE2D; | T39 | ochoa | G antigen 2D (GAGE-2D) (Cancer/testis antigen 4.8) (CT4.8) (G antigen 8) (GAGE-8) | None |
Q9UKS6 | PACSIN3 | S344 | ochoa | Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511) | Plays a role in endocytosis and regulates internalization of plasma membrane proteins. Overexpression impairs internalization of SLC2A1/GLUT1 and TRPV4 and increases the levels of SLC2A1/GLUT1 and TRPV4 at the cell membrane. Inhibits the TRPV4 calcium channel activity (By similarity). {ECO:0000250, ECO:0000269|PubMed:11082044}. |
Q9Y4B5 | MTCL1 | T315 | ochoa | Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2) | Microtubule-associated factor involved in the late phase of epithelial polarization and microtubule dynamics regulation (PubMed:23902687). Plays a role in the development and maintenance of non-centrosomal microtubule bundles at the lateral membrane in polarized epithelial cells (PubMed:23902687). Required for faithful chromosome segregation during mitosis (PubMed:33587225). {ECO:0000269|PubMed:23902687, ECO:0000269|PubMed:33587225}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-69560 | Transcriptional activation of p53 responsive genes | 0.000002 | 5.654 |
R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 | 0.000002 | 5.654 |
R-HSA-936837 | Ion transport by P-type ATPases | 0.000012 | 4.928 |
R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | 0.000079 | 4.102 |
R-HSA-71288 | Creatine metabolism | 0.000152 | 3.818 |
R-HSA-5578775 | Ion homeostasis | 0.000139 | 3.856 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 0.000190 | 3.720 |
R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | 0.000284 | 3.546 |
R-HSA-8941855 | RUNX3 regulates CDKN1A transcription | 0.000503 | 3.299 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.001644 | 2.784 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.001644 | 2.784 |
R-HSA-983712 | Ion channel transport | 0.001561 | 2.807 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.002383 | 2.623 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.003053 | 2.515 |
R-HSA-9702518 | STAT5 activation downstream of FLT3 ITD mutants | 0.003349 | 2.475 |
R-HSA-5576891 | Cardiac conduction | 0.003019 | 2.520 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.003434 | 2.464 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.004837 | 2.315 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.005199 | 2.284 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.005451 | 2.263 |
R-HSA-9703648 | Signaling by FLT3 ITD and TKD mutants | 0.006678 | 2.175 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 0.007559 | 2.122 |
R-HSA-9614085 | FOXO-mediated transcription | 0.010161 | 1.993 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.012540 | 1.902 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.012540 | 1.902 |
R-HSA-9682385 | FLT3 signaling in disease | 0.013267 | 1.877 |
R-HSA-397014 | Muscle contraction | 0.014540 | 1.837 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.018958 | 1.722 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.026159 | 1.582 |
R-HSA-1640170 | Cell Cycle | 0.027388 | 1.562 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.030725 | 1.513 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 0.031784 | 1.498 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.032805 | 1.484 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 0.066353 | 1.178 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 0.081324 | 1.090 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 0.103339 | 0.986 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 0.103339 | 0.986 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.196146 | 0.707 |
R-HSA-72187 | mRNA 3'-end processing | 0.215449 | 0.667 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.249658 | 0.603 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.249658 | 0.603 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.258730 | 0.587 |
R-HSA-156711 | Polo-like kinase mediated events | 0.088721 | 1.052 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 0.196146 | 0.707 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.237392 | 0.625 |
R-HSA-187577 | SCF(Skp2)-mediated degradation of p27/p21 | 0.189609 | 0.722 |
R-HSA-1614603 | Cysteine formation from homocysteine | 0.039573 | 1.403 |
R-HSA-9927354 | Co-stimulation by ICOS | 0.043445 | 1.362 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 0.066353 | 1.178 |
R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) | 0.066353 | 1.178 |
R-HSA-392451 | G beta:gamma signalling through PI3Kgamma | 0.110561 | 0.956 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.114151 | 0.943 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 0.124834 | 0.904 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.243549 | 0.613 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.261730 | 0.582 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.189609 | 0.722 |
R-HSA-69236 | G1 Phase | 0.189609 | 0.722 |
R-HSA-9620244 | Long-term potentiation | 0.117726 | 0.929 |
R-HSA-9639288 | Amino acids regulate mTORC1 | 0.218621 | 0.660 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.264718 | 0.577 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.270658 | 0.568 |
R-HSA-1236973 | Cross-presentation of particulate exogenous antigens (phagosomes) | 0.051142 | 1.291 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 0.135390 | 0.868 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.169681 | 0.770 |
R-HSA-9711097 | Cellular response to starvation | 0.158875 | 0.799 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.202632 | 0.693 |
R-HSA-69275 | G2/M Transition | 0.050327 | 1.298 |
R-HSA-375165 | NCAM signaling for neurite out-growth | 0.246610 | 0.608 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.051526 | 1.288 |
R-HSA-9609523 | Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | 0.096059 | 1.017 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 0.145821 | 0.836 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.192884 | 0.715 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.177434 | 0.751 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.095948 | 1.018 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.151842 | 0.819 |
R-HSA-390696 | Adrenoceptors | 0.043445 | 1.362 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 0.103339 | 0.986 |
R-HSA-194138 | Signaling by VEGF | 0.109938 | 0.959 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 0.124834 | 0.904 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 0.142358 | 0.847 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 0.149271 | 0.826 |
R-HSA-1614517 | Sulfide oxidation to sulfate | 0.085030 | 1.070 |
R-HSA-8953854 | Metabolism of RNA | 0.263253 | 0.580 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.212434 | 0.673 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.106957 | 0.971 |
R-HSA-397795 | G-protein beta:gamma signalling | 0.145821 | 0.836 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.203650 | 0.691 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.192884 | 0.715 |
R-HSA-198323 | AKT phosphorylates targets in the cytosol | 0.062573 | 1.204 |
R-HSA-5635838 | Activation of SMO | 0.077604 | 1.110 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.173036 | 0.762 |
R-HSA-389356 | Co-stimulation by CD28 | 0.202632 | 0.693 |
R-HSA-2408508 | Metabolism of ingested SeMet, Sec, MeSec into H2Se | 0.156129 | 0.807 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 0.246610 | 0.608 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.099710 | 1.001 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.167395 | 0.776 |
R-HSA-72312 | rRNA processing | 0.270612 | 0.568 |
R-HSA-73894 | DNA Repair | 0.198267 | 0.703 |
R-HSA-2559583 | Cellular Senescence | 0.191935 | 0.717 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.145821 | 0.836 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 0.162932 | 0.788 |
R-HSA-375280 | Amine ligand-binding receptors | 0.189609 | 0.722 |
R-HSA-114604 | GPVI-mediated activation cascade | 0.159537 | 0.797 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 0.138881 | 0.857 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.149271 | 0.826 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.162932 | 0.788 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.070903 | 1.149 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.092229 | 1.035 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.202632 | 0.693 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.246610 | 0.608 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.145821 | 0.836 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 0.110561 | 0.956 |
R-HSA-1614635 | Sulfur amino acid metabolism | 0.056696 | 1.246 |
R-HSA-5693538 | Homology Directed Repair | 0.099710 | 1.001 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.224928 | 0.648 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 0.258730 | 0.587 |
R-HSA-1614558 | Degradation of cysteine and homocysteine | 0.192884 | 0.715 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 0.179705 | 0.745 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.261730 | 0.582 |
R-HSA-212436 | Generic Transcription Pathway | 0.180855 | 0.743 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.149866 | 0.824 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.228062 | 0.642 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 0.246610 | 0.608 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.159537 | 0.797 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.068350 | 1.165 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.127112 | 0.896 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 0.228062 | 0.642 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.169681 | 0.770 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 0.100973 | 0.996 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.044013 | 1.356 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.209539 | 0.679 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.170742 | 0.768 |
R-HSA-9679506 | SARS-CoV Infections | 0.203193 | 0.692 |
R-HSA-5632684 | Hedgehog 'on' state | 0.273611 | 0.563 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.276552 | 0.558 |
R-HSA-8939211 | ESR-mediated signaling | 0.278094 | 0.556 |
R-HSA-74160 | Gene expression (Transcription) | 0.279040 | 0.554 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.279480 | 0.554 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.282398 | 0.549 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 0.282398 | 0.549 |
R-HSA-380287 | Centrosome maturation | 0.285303 | 0.545 |
R-HSA-5689603 | UCH proteinases | 0.288197 | 0.540 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.293951 | 0.532 |
R-HSA-4086400 | PCP/CE pathway | 0.293951 | 0.532 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.302495 | 0.519 |
R-HSA-5688426 | Deubiquitination | 0.304986 | 0.516 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 0.305321 | 0.515 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.305321 | 0.515 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.310938 | 0.507 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 0.310938 | 0.507 |
R-HSA-438064 | Post NMDA receptor activation events | 0.322039 | 0.492 |
R-HSA-9711123 | Cellular response to chemical stress | 0.324312 | 0.489 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.324786 | 0.488 |
R-HSA-156902 | Peptide chain elongation | 0.324786 | 0.488 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.330248 | 0.481 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 0.332963 | 0.478 |
R-HSA-975956 | Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | 0.335667 | 0.474 |
R-HSA-156842 | Eukaryotic Translation Elongation | 0.338360 | 0.471 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.340566 | 0.468 |
R-HSA-162582 | Signal Transduction | 0.342605 | 0.465 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.343714 | 0.464 |
R-HSA-9954716 | ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ri... | 0.346375 | 0.460 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.346375 | 0.460 |
R-HSA-9954709 | Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | 0.349026 | 0.457 |
R-HSA-72764 | Eukaryotic Translation Termination | 0.349026 | 0.457 |
R-HSA-72689 | Formation of a pool of free 40S subunits | 0.349026 | 0.457 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.351665 | 0.454 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.354295 | 0.451 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.355244 | 0.449 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.363999 | 0.439 |
R-HSA-2408557 | Selenocysteine synthesis | 0.364707 | 0.438 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.365454 | 0.437 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 0.367284 | 0.435 |
R-HSA-1483255 | PI Metabolism | 0.367284 | 0.435 |
R-HSA-192823 | Viral mRNA Translation | 0.369851 | 0.432 |
R-HSA-9633012 | Response of EIF2AK4 (GCN2) to amino acid deficiency | 0.372408 | 0.429 |
R-HSA-5696398 | Nucleotide Excision Repair | 0.377490 | 0.423 |
R-HSA-382551 | Transport of small molecules | 0.380091 | 0.420 |
R-HSA-1799339 | SRP-dependent cotranslational protein targeting to membrane | 0.382533 | 0.417 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.385039 | 0.414 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.385039 | 0.414 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.385039 | 0.414 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.394963 | 0.403 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.394963 | 0.403 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.409554 | 0.388 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.409554 | 0.388 |
R-HSA-373760 | L1CAM interactions | 0.409554 | 0.388 |
R-HSA-2262752 | Cellular responses to stress | 0.410204 | 0.387 |
R-HSA-68875 | Mitotic Prophase | 0.419088 | 0.378 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.426139 | 0.370 |
R-HSA-2132295 | MHC class II antigen presentation | 0.426139 | 0.370 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.430887 | 0.366 |
R-HSA-69206 | G1/S Transition | 0.433106 | 0.363 |
R-HSA-69481 | G2/M Checkpoints | 0.437704 | 0.359 |
R-HSA-5683057 | MAPK family signaling cascades | 0.437797 | 0.359 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.444533 | 0.352 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.459610 | 0.338 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.462346 | 0.335 |
R-HSA-9948299 | Ribosome-associated quality control | 0.466710 | 0.331 |
R-HSA-5358351 | Signaling by Hedgehog | 0.466710 | 0.331 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.479596 | 0.319 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.485923 | 0.313 |
R-HSA-68886 | M Phase | 0.486195 | 0.313 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.488015 | 0.312 |
R-HSA-69242 | S Phase | 0.490099 | 0.310 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.496301 | 0.304 |
R-HSA-9824446 | Viral Infection Pathways | 0.497486 | 0.303 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.498351 | 0.302 |
R-HSA-9609507 | Protein localization | 0.500394 | 0.301 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.504454 | 0.297 |
R-HSA-8953897 | Cellular responses to stimuli | 0.511518 | 0.291 |
R-HSA-877300 | Interferon gamma signaling | 0.512477 | 0.290 |
R-HSA-9006936 | Signaling by TGFB family members | 0.514463 | 0.289 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.514463 | 0.289 |
R-HSA-72306 | tRNA processing | 0.535788 | 0.271 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.545173 | 0.263 |
R-HSA-168255 | Influenza Infection | 0.552547 | 0.258 |
R-HSA-5617833 | Cilium Assembly | 0.572223 | 0.242 |
R-HSA-68877 | Mitotic Prometaphase | 0.577440 | 0.238 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.579165 | 0.237 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.592717 | 0.227 |
R-HSA-376176 | Signaling by ROBO receptors | 0.594381 | 0.226 |
R-HSA-72172 | mRNA Splicing | 0.597688 | 0.224 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.610652 | 0.214 |
R-HSA-8951664 | Neddylation | 0.624746 | 0.204 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.632358 | 0.199 |
R-HSA-157118 | Signaling by NOTCH | 0.652871 | 0.185 |
R-HSA-422475 | Axon guidance | 0.670934 | 0.173 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.674937 | 0.171 |
R-HSA-416476 | G alpha (q) signalling events | 0.685446 | 0.164 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.698113 | 0.156 |
R-HSA-9675108 | Nervous system development | 0.704719 | 0.152 |
R-HSA-1483257 | Phospholipid metabolism | 0.723101 | 0.141 |
R-HSA-195721 | Signaling by WNT | 0.726500 | 0.139 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.730807 | 0.136 |
R-HSA-449147 | Signaling by Interleukins | 0.740379 | 0.131 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.750204 | 0.125 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.753275 | 0.123 |
R-HSA-199991 | Membrane Trafficking | 0.757932 | 0.120 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.808249 | 0.092 |
R-HSA-913531 | Interferon Signaling | 0.808249 | 0.092 |
R-HSA-1280218 | Adaptive Immune System | 0.813305 | 0.090 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 0.816789 | 0.088 |
R-HSA-597592 | Post-translational protein modification | 0.821245 | 0.086 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.827123 | 0.082 |
R-HSA-5663205 | Infectious disease | 0.833959 | 0.079 |
R-HSA-1643685 | Disease | 0.836729 | 0.077 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.836874 | 0.077 |
R-HSA-388396 | GPCR downstream signalling | 0.837144 | 0.077 |
R-HSA-72766 | Translation | 0.841547 | 0.075 |
R-HSA-109582 | Hemostasis | 0.842322 | 0.075 |
R-HSA-5653656 | Vesicle-mediated transport | 0.854157 | 0.068 |
R-HSA-6798695 | Neutrophil degranulation | 0.858954 | 0.066 |
R-HSA-112316 | Neuronal System | 0.865265 | 0.063 |
R-HSA-372790 | Signaling by GPCR | 0.875882 | 0.058 |
R-HSA-168256 | Immune System | 0.896370 | 0.048 |
R-HSA-1266738 | Developmental Biology | 0.911634 | 0.040 |
R-HSA-168249 | Innate Immune System | 0.917767 | 0.037 |
R-HSA-500792 | GPCR ligand binding | 0.918742 | 0.037 |
R-HSA-392499 | Metabolism of proteins | 0.940607 | 0.027 |
R-HSA-1430728 | Metabolism | 0.997082 | 0.001 |
R-HSA-556833 | Metabolism of lipids | 0.998331 | 0.001 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
CDK18 |
0.733 | 0.699 | 1 | 0.841 |
CDK19 |
0.732 | 0.721 | 1 | 0.818 |
P38G |
0.729 | 0.681 | 1 | 0.877 |
CDK8 |
0.728 | 0.719 | 1 | 0.786 |
P38B |
0.728 | 0.733 | 1 | 0.800 |
CDK17 |
0.727 | 0.679 | 1 | 0.871 |
CDK16 |
0.725 | 0.661 | 1 | 0.859 |
P38D |
0.724 | 0.674 | 1 | 0.860 |
HIPK2 |
0.722 | 0.610 | 1 | 0.828 |
JNK2 |
0.722 | 0.675 | 1 | 0.834 |
ERK1 |
0.720 | 0.695 | 1 | 0.812 |
CDK1 |
0.714 | 0.625 | 1 | 0.836 |
JNK3 |
0.714 | 0.656 | 1 | 0.808 |
MAK |
0.714 | 0.604 | -2 | 0.751 |
P38A |
0.714 | 0.720 | 1 | 0.739 |
CDK3 |
0.713 | 0.561 | 1 | 0.869 |
CDK5 |
0.711 | 0.629 | 1 | 0.777 |
DYRK2 |
0.710 | 0.594 | 1 | 0.749 |
KIS |
0.710 | 0.549 | 1 | 0.763 |
DYRK4 |
0.710 | 0.584 | 1 | 0.838 |
CDK7 |
0.707 | 0.641 | 1 | 0.798 |
JNK1 |
0.703 | 0.595 | 1 | 0.843 |
CDK13 |
0.702 | 0.600 | 1 | 0.815 |
CDK12 |
0.701 | 0.604 | 1 | 0.830 |
CDK14 |
0.701 | 0.624 | 1 | 0.807 |
DYRK1B |
0.700 | 0.550 | 1 | 0.802 |
DYRK1A |
0.698 | 0.533 | 1 | 0.701 |
HIPK1 |
0.696 | 0.520 | 1 | 0.731 |
CLK3 |
0.692 | 0.372 | 1 | 0.522 |
HIPK4 |
0.691 | 0.451 | 1 | 0.542 |
ERK2 |
0.690 | 0.619 | 1 | 0.768 |
CDK9 |
0.687 | 0.568 | 1 | 0.807 |
CDK10 |
0.685 | 0.543 | 1 | 0.824 |
ICK |
0.685 | 0.472 | -3 | 0.642 |
CDK6 |
0.680 | 0.558 | 1 | 0.816 |
MOK |
0.680 | 0.484 | 1 | 0.628 |
HIPK3 |
0.680 | 0.498 | 1 | 0.689 |
CDK4 |
0.680 | 0.580 | 1 | 0.837 |
DYRK3 |
0.675 | 0.398 | 1 | 0.694 |
MTOR |
0.675 | 0.355 | 1 | 0.335 |
CDKL5 |
0.675 | 0.293 | -3 | 0.609 |
CDK2 |
0.674 | 0.437 | 1 | 0.723 |
ERK5 |
0.673 | 0.327 | 1 | 0.465 |
CLK2 |
0.673 | 0.273 | -3 | 0.607 |
NLK |
0.671 | 0.483 | 1 | 0.550 |
CDKL1 |
0.670 | 0.249 | -3 | 0.616 |
SRPK1 |
0.668 | 0.217 | -3 | 0.592 |
GRK7 |
0.664 | 0.115 | 1 | 0.226 |
PRP4 |
0.661 | 0.324 | -3 | 0.596 |
MOS |
0.660 | 0.044 | 1 | 0.259 |
CLK1 |
0.660 | 0.246 | -3 | 0.592 |
FAM20C |
0.659 | 0.155 | 2 | 0.668 |
CDC7 |
0.659 | 0.021 | 1 | 0.229 |
SRPK2 |
0.659 | 0.173 | -3 | 0.530 |
CLK4 |
0.658 | 0.219 | -3 | 0.612 |
COT |
0.657 | -0.019 | 2 | 0.633 |
BMPR1B |
0.656 | 0.008 | 1 | 0.227 |
PRPK |
0.652 | 0.013 | -1 | 0.549 |
NDR2 |
0.652 | 0.045 | -3 | 0.677 |
MPSK1 |
0.652 | 0.249 | 1 | 0.240 |
LATS1 |
0.651 | 0.066 | -3 | 0.688 |
PIM3 |
0.650 | -0.014 | -3 | 0.669 |
ATR |
0.650 | 0.024 | 1 | 0.216 |
TGFBR1 |
0.650 | 0.010 | -2 | 0.487 |
TBK1 |
0.649 | -0.033 | 1 | 0.123 |
ERK7 |
0.648 | 0.186 | 2 | 0.367 |
SRPK3 |
0.647 | 0.136 | -3 | 0.560 |
GSK3A |
0.647 | 0.167 | 4 | 0.320 |
BMPR2 |
0.646 | -0.114 | -2 | 0.497 |
PDHK4 |
0.646 | -0.028 | 1 | 0.232 |
GRK1 |
0.644 | -0.005 | -2 | 0.444 |
SKMLCK |
0.644 | -0.035 | -2 | 0.446 |
IKKA |
0.643 | -0.033 | -2 | 0.370 |
GRK5 |
0.643 | -0.080 | -3 | 0.681 |
PIM1 |
0.643 | 0.003 | -3 | 0.630 |
BMPR1A |
0.642 | -0.008 | 1 | 0.214 |
MARK4 |
0.641 | 0.011 | 4 | 0.616 |
PRKD1 |
0.641 | -0.025 | -3 | 0.646 |
LATS2 |
0.641 | -0.018 | -5 | 0.609 |
ALK4 |
0.641 | -0.037 | -2 | 0.498 |
MAPKAPK2 |
0.641 | -0.005 | -3 | 0.590 |
ALK2 |
0.641 | -0.023 | -2 | 0.483 |
CAMK2G |
0.640 | -0.053 | 2 | 0.590 |
CAMK1B |
0.640 | -0.060 | -3 | 0.665 |
DNAPK |
0.639 | 0.026 | 1 | 0.172 |
ACVR2B |
0.639 | -0.049 | -2 | 0.489 |
IKKE |
0.639 | -0.112 | 1 | 0.122 |
TGFBR2 |
0.638 | -0.093 | -2 | 0.500 |
ACVR2A |
0.638 | -0.048 | -2 | 0.489 |
PKCD |
0.638 | -0.015 | 2 | 0.568 |
CAMK2B |
0.638 | -0.012 | 2 | 0.583 |
RAF1 |
0.637 | -0.146 | 1 | 0.176 |
RSK2 |
0.637 | -0.027 | -3 | 0.612 |
CAMLCK |
0.637 | -0.050 | -2 | 0.419 |
PKN3 |
0.637 | -0.056 | -3 | 0.640 |
ATM |
0.637 | -0.034 | 1 | 0.184 |
PDHK1 |
0.636 | -0.125 | 1 | 0.198 |
NIK |
0.636 | -0.095 | -3 | 0.675 |
NUAK2 |
0.636 | -0.033 | -3 | 0.661 |
MLK2 |
0.635 | -0.042 | 2 | 0.587 |
MLK3 |
0.635 | -0.008 | 2 | 0.547 |
GRK6 |
0.635 | -0.069 | 1 | 0.203 |
CAMK2D |
0.635 | -0.057 | -3 | 0.626 |
GCN2 |
0.634 | -0.155 | 2 | 0.545 |
IKKB |
0.634 | -0.156 | -2 | 0.336 |
P90RSK |
0.634 | -0.028 | -3 | 0.606 |
NDR1 |
0.633 | -0.054 | -3 | 0.665 |
CK2A2 |
0.633 | 0.050 | 1 | 0.209 |
TLK2 |
0.633 | -0.072 | 1 | 0.147 |
CAMK2A |
0.633 | -0.018 | 2 | 0.568 |
MLK1 |
0.633 | -0.103 | 2 | 0.597 |
DSTYK |
0.633 | -0.163 | 2 | 0.657 |
BCKDK |
0.632 | -0.071 | -1 | 0.568 |
MST4 |
0.632 | -0.031 | 2 | 0.656 |
DAPK2 |
0.632 | -0.080 | -3 | 0.662 |
MASTL |
0.632 | -0.114 | -2 | 0.437 |
GRK4 |
0.631 | -0.111 | -2 | 0.470 |
PKCA |
0.631 | 0.010 | 2 | 0.525 |
CHAK2 |
0.631 | -0.068 | -1 | 0.455 |
GRK2 |
0.631 | -0.053 | -2 | 0.399 |
RSK4 |
0.630 | -0.009 | -3 | 0.591 |
VRK2 |
0.630 | 0.018 | 1 | 0.271 |
MAPKAPK3 |
0.630 | -0.066 | -3 | 0.611 |
PLK3 |
0.629 | -0.052 | 2 | 0.537 |
QSK |
0.629 | -0.001 | 4 | 0.599 |
WNK1 |
0.629 | -0.086 | -2 | 0.464 |
MLK4 |
0.628 | -0.052 | 2 | 0.525 |
NIM1 |
0.628 | 0.011 | 3 | 0.699 |
TSSK1 |
0.628 | -0.061 | -3 | 0.687 |
CHK1 |
0.628 | -0.058 | -3 | 0.677 |
AMPKA1 |
0.628 | -0.073 | -3 | 0.673 |
RSK3 |
0.628 | -0.049 | -3 | 0.615 |
NEK6 |
0.628 | -0.130 | -2 | 0.493 |
RIPK3 |
0.627 | -0.108 | 3 | 0.675 |
DLK |
0.627 | -0.164 | 1 | 0.189 |
PKACB |
0.627 | -0.026 | -2 | 0.281 |
MEK1 |
0.627 | -0.099 | 2 | 0.583 |
SGK3 |
0.626 | -0.018 | -3 | 0.627 |
PKCG |
0.626 | -0.018 | 2 | 0.530 |
PKCB |
0.626 | -0.031 | 2 | 0.538 |
PRKD2 |
0.626 | -0.050 | -3 | 0.606 |
YSK4 |
0.626 | -0.143 | 1 | 0.145 |
PLK1 |
0.626 | -0.118 | -2 | 0.457 |
MARK3 |
0.626 | -0.006 | 4 | 0.551 |
PAK1 |
0.625 | -0.058 | -2 | 0.395 |
AMPKA2 |
0.624 | -0.056 | -3 | 0.648 |
PKN2 |
0.624 | -0.097 | -3 | 0.654 |
ULK2 |
0.624 | -0.209 | 2 | 0.550 |
P70S6KB |
0.623 | -0.067 | -3 | 0.618 |
PKACG |
0.623 | -0.071 | -2 | 0.333 |
TAO3 |
0.623 | 0.001 | 1 | 0.192 |
MARK2 |
0.623 | -0.017 | 4 | 0.521 |
PKR |
0.623 | -0.116 | 1 | 0.189 |
TTBK2 |
0.622 | -0.143 | 2 | 0.482 |
PRKX |
0.622 | -0.012 | -3 | 0.580 |
HUNK |
0.622 | -0.185 | 2 | 0.565 |
AURC |
0.622 | -0.059 | -2 | 0.284 |
PASK |
0.622 | -0.026 | -3 | 0.671 |
SIK |
0.621 | -0.023 | -3 | 0.594 |
CK2A1 |
0.621 | 0.026 | 1 | 0.202 |
GRK3 |
0.621 | -0.055 | -2 | 0.384 |
NEK7 |
0.621 | -0.229 | -3 | 0.584 |
MSK2 |
0.620 | -0.063 | -3 | 0.585 |
PLK4 |
0.620 | -0.066 | 2 | 0.430 |
IRE2 |
0.620 | -0.080 | 2 | 0.560 |
GSK3B |
0.620 | 0.024 | 4 | 0.307 |
TSSK2 |
0.620 | -0.127 | -5 | 0.669 |
NEK9 |
0.620 | -0.204 | 2 | 0.592 |
IRE1 |
0.619 | -0.106 | 1 | 0.163 |
DCAMKL1 |
0.619 | -0.053 | -3 | 0.642 |
CK1E |
0.619 | 0.014 | -3 | 0.489 |
SMG1 |
0.619 | -0.086 | 1 | 0.190 |
NUAK1 |
0.618 | -0.068 | -3 | 0.618 |
AKT2 |
0.618 | -0.027 | -3 | 0.548 |
PLK2 |
0.618 | 0.003 | -3 | 0.695 |
MEKK2 |
0.618 | -0.101 | 2 | 0.566 |
PIM2 |
0.618 | -0.035 | -3 | 0.587 |
SBK |
0.617 | 0.067 | -3 | 0.456 |
MSK1 |
0.617 | -0.060 | -3 | 0.595 |
WNK3 |
0.617 | -0.186 | 1 | 0.154 |
ANKRD3 |
0.617 | -0.257 | 1 | 0.185 |
MARK1 |
0.617 | -0.038 | 4 | 0.570 |
RIPK1 |
0.616 | -0.185 | 1 | 0.160 |
PKCZ |
0.616 | -0.074 | 2 | 0.544 |
TLK1 |
0.616 | -0.142 | -2 | 0.492 |
PERK |
0.616 | -0.171 | -2 | 0.490 |
QIK |
0.615 | -0.082 | -3 | 0.629 |
PKCH |
0.615 | -0.080 | 2 | 0.516 |
PINK1 |
0.615 | 0.010 | 1 | 0.380 |
PAK3 |
0.615 | -0.107 | -2 | 0.364 |
BRSK1 |
0.614 | -0.067 | -3 | 0.626 |
MNK2 |
0.614 | -0.087 | -2 | 0.353 |
MST3 |
0.614 | -0.065 | 2 | 0.614 |
MEK5 |
0.614 | -0.162 | 2 | 0.578 |
PRKD3 |
0.613 | -0.072 | -3 | 0.588 |
MST2 |
0.613 | -0.080 | 1 | 0.163 |
ULK1 |
0.613 | -0.207 | -3 | 0.559 |
BRAF |
0.613 | -0.131 | -4 | 0.798 |
GCK |
0.613 | -0.042 | 1 | 0.185 |
MEKK1 |
0.613 | -0.139 | 1 | 0.162 |
MNK1 |
0.613 | -0.080 | -2 | 0.355 |
PAK2 |
0.612 | -0.104 | -2 | 0.376 |
CAMK4 |
0.612 | -0.159 | -3 | 0.639 |
AURA |
0.612 | -0.079 | -2 | 0.269 |
ZAK |
0.612 | -0.153 | 1 | 0.150 |
SGK1 |
0.612 | 0.002 | -3 | 0.503 |
PHKG1 |
0.611 | -0.115 | -3 | 0.644 |
WNK4 |
0.611 | -0.098 | -2 | 0.482 |
MEKK3 |
0.611 | -0.165 | 1 | 0.174 |
MELK |
0.611 | -0.126 | -3 | 0.626 |
CK1D |
0.611 | 0.001 | -3 | 0.437 |
PAK6 |
0.611 | -0.064 | -2 | 0.290 |
PKG2 |
0.610 | -0.087 | -2 | 0.283 |
PKACA |
0.610 | -0.047 | -2 | 0.247 |
HRI |
0.610 | -0.197 | -2 | 0.499 |
MAP3K15 |
0.609 | -0.007 | 1 | 0.154 |
PDK1 |
0.609 | -0.062 | 1 | 0.194 |
GAK |
0.609 | -0.073 | 1 | 0.250 |
NEK5 |
0.609 | -0.176 | 1 | 0.157 |
BRSK2 |
0.609 | -0.094 | -3 | 0.630 |
AURB |
0.609 | -0.092 | -2 | 0.277 |
DRAK1 |
0.608 | -0.145 | 1 | 0.196 |
TNIK |
0.608 | -0.043 | 3 | 0.690 |
TAO2 |
0.607 | -0.074 | 2 | 0.616 |
DCAMKL2 |
0.607 | -0.082 | -3 | 0.638 |
NEK11 |
0.607 | -0.113 | 1 | 0.185 |
AKT1 |
0.607 | -0.049 | -3 | 0.564 |
MYLK4 |
0.607 | -0.105 | -2 | 0.331 |
NEK2 |
0.606 | -0.193 | 2 | 0.570 |
KHS1 |
0.606 | -0.024 | 1 | 0.157 |
PBK |
0.606 | -0.028 | 1 | 0.214 |
HGK |
0.605 | -0.072 | 3 | 0.689 |
MEKK6 |
0.605 | -0.058 | 1 | 0.160 |
PKCT |
0.604 | -0.086 | 2 | 0.521 |
CAMK1D |
0.603 | -0.068 | -3 | 0.550 |
CHAK1 |
0.603 | -0.194 | 2 | 0.518 |
ROCK2 |
0.603 | -0.046 | -3 | 0.640 |
MINK |
0.603 | -0.095 | 1 | 0.142 |
SMMLCK |
0.602 | -0.101 | -3 | 0.621 |
VRK1 |
0.602 | -0.114 | 2 | 0.609 |
LKB1 |
0.602 | -0.104 | -3 | 0.590 |
PKCE |
0.601 | -0.049 | 2 | 0.528 |
AKT3 |
0.601 | -0.033 | -3 | 0.512 |
EEF2K |
0.601 | -0.072 | 3 | 0.655 |
HPK1 |
0.601 | -0.081 | 1 | 0.182 |
KHS2 |
0.600 | -0.034 | 1 | 0.177 |
DAPK3 |
0.600 | -0.087 | -3 | 0.628 |
LRRK2 |
0.600 | -0.078 | 2 | 0.596 |
BUB1 |
0.600 | -0.044 | -5 | 0.623 |
CAMK1G |
0.599 | -0.107 | -3 | 0.566 |
CK1A2 |
0.599 | -0.023 | -3 | 0.443 |
MST1 |
0.599 | -0.122 | 1 | 0.144 |
HASPIN |
0.598 | -0.021 | -1 | 0.378 |
PAK5 |
0.598 | -0.085 | -2 | 0.282 |
CK1G1 |
0.597 | -0.038 | -3 | 0.490 |
IRAK4 |
0.597 | -0.178 | 1 | 0.137 |
AAK1 |
0.597 | 0.001 | 1 | 0.238 |
MAPKAPK5 |
0.596 | -0.135 | -3 | 0.533 |
PKCI |
0.595 | -0.096 | 2 | 0.529 |
CAMKK2 |
0.595 | -0.194 | -2 | 0.321 |
TTK |
0.595 | -0.089 | -2 | 0.502 |
SLK |
0.595 | -0.122 | -2 | 0.366 |
ALPHAK3 |
0.595 | -0.025 | -1 | 0.427 |
SSTK |
0.595 | -0.120 | 4 | 0.578 |
BIKE |
0.595 | -0.040 | 1 | 0.237 |
P70S6K |
0.595 | -0.090 | -3 | 0.546 |
NEK8 |
0.594 | -0.238 | 2 | 0.585 |
NEK4 |
0.594 | -0.179 | 1 | 0.134 |
LOK |
0.594 | -0.137 | -2 | 0.357 |
DAPK1 |
0.594 | -0.089 | -3 | 0.610 |
TAK1 |
0.594 | -0.215 | 1 | 0.154 |
PAK4 |
0.593 | -0.079 | -2 | 0.293 |
YSK1 |
0.593 | -0.096 | 2 | 0.583 |
CAMKK1 |
0.593 | -0.245 | -2 | 0.314 |
CAMK1A |
0.592 | -0.066 | -3 | 0.526 |
MRCKB |
0.592 | -0.069 | -3 | 0.580 |
NEK1 |
0.592 | -0.168 | 1 | 0.136 |
MRCKA |
0.591 | -0.077 | -3 | 0.597 |
OSR1 |
0.591 | -0.109 | 2 | 0.545 |
TTBK1 |
0.591 | -0.165 | 2 | 0.425 |
DMPK1 |
0.590 | -0.044 | -3 | 0.605 |
CHK2 |
0.590 | -0.079 | -3 | 0.513 |
PKN1 |
0.589 | -0.087 | -3 | 0.560 |
SNRK |
0.588 | -0.208 | 2 | 0.460 |
MEK2 |
0.588 | -0.184 | 2 | 0.560 |
ASK1 |
0.588 | -0.072 | 1 | 0.154 |
PHKG2 |
0.588 | -0.136 | -3 | 0.622 |
CRIK |
0.586 | -0.041 | -3 | 0.564 |
MYO3A |
0.585 | -0.073 | 1 | 0.161 |
ROCK1 |
0.584 | -0.073 | -3 | 0.601 |
MYO3B |
0.583 | -0.087 | 2 | 0.606 |
IRAK1 |
0.581 | -0.262 | -1 | 0.431 |
NEK3 |
0.581 | -0.152 | 1 | 0.141 |
TAO1 |
0.580 | -0.100 | 1 | 0.138 |
PKG1 |
0.578 | -0.100 | -2 | 0.218 |
YANK3 |
0.577 | -0.056 | 2 | 0.263 |
PDHK3_TYR |
0.576 | 0.190 | 4 | 0.703 |
RIPK2 |
0.573 | -0.247 | 1 | 0.126 |
CK1A |
0.572 | -0.032 | -3 | 0.381 |
STK33 |
0.570 | -0.185 | 2 | 0.391 |
STLK3 |
0.570 | -0.182 | 1 | 0.128 |
PKMYT1_TYR |
0.569 | 0.161 | 3 | 0.752 |
MAP2K6_TYR |
0.568 | 0.079 | -1 | 0.542 |
PDHK4_TYR |
0.568 | 0.084 | 2 | 0.623 |
MAP2K4_TYR |
0.567 | 0.087 | -1 | 0.566 |
PDHK1_TYR |
0.566 | 0.067 | -1 | 0.522 |
LIMK2_TYR |
0.565 | 0.099 | -3 | 0.668 |
TESK1_TYR |
0.563 | 0.007 | 3 | 0.774 |
MAP2K7_TYR |
0.561 | -0.008 | 2 | 0.617 |
BMPR2_TYR |
0.560 | -0.005 | -1 | 0.515 |
TXK |
0.559 | -0.012 | 1 | 0.199 |
YES1 |
0.554 | -0.038 | -1 | 0.520 |
CSF1R |
0.553 | -0.028 | 3 | 0.688 |
PINK1_TYR |
0.552 | -0.140 | 1 | 0.231 |
RET |
0.550 | -0.127 | 1 | 0.173 |
LIMK1_TYR |
0.550 | -0.030 | 2 | 0.621 |
YANK2 |
0.549 | -0.071 | 2 | 0.272 |
EPHB4 |
0.549 | -0.083 | -1 | 0.478 |
JAK2 |
0.549 | -0.089 | 1 | 0.172 |
CK1G3 |
0.548 | -0.062 | -3 | 0.346 |
ABL2 |
0.548 | -0.077 | -1 | 0.471 |
FYN |
0.547 | -0.036 | -1 | 0.468 |
FGFR2 |
0.547 | -0.050 | 3 | 0.716 |
FGR |
0.547 | -0.140 | 1 | 0.178 |
FER |
0.547 | -0.130 | 1 | 0.194 |
INSRR |
0.546 | -0.083 | 3 | 0.662 |
ROS1 |
0.546 | -0.098 | 3 | 0.654 |
MST1R |
0.546 | -0.110 | 3 | 0.702 |
SRMS |
0.546 | -0.103 | 1 | 0.178 |
EPHA6 |
0.545 | -0.112 | -1 | 0.474 |
DDR1 |
0.545 | -0.099 | 4 | 0.590 |
TYK2 |
0.544 | -0.177 | 1 | 0.156 |
ABL1 |
0.544 | -0.086 | -1 | 0.479 |
TYRO3 |
0.544 | -0.145 | 3 | 0.675 |
LCK |
0.543 | -0.087 | -1 | 0.477 |
EPHA4 |
0.543 | -0.065 | 2 | 0.549 |
JAK1 |
0.542 | -0.064 | 1 | 0.139 |
FGFR1 |
0.542 | -0.062 | 3 | 0.678 |
MERTK |
0.542 | -0.102 | 3 | 0.702 |
BLK |
0.542 | -0.069 | -1 | 0.475 |
ITK |
0.542 | -0.106 | -1 | 0.455 |
NEK10_TYR |
0.542 | -0.094 | 1 | 0.139 |
KIT |
0.541 | -0.103 | 3 | 0.688 |
EGFR |
0.539 | -0.062 | 1 | 0.131 |
HCK |
0.539 | -0.137 | -1 | 0.479 |
EPHB2 |
0.538 | -0.116 | -1 | 0.462 |
TNNI3K_TYR |
0.538 | -0.071 | 1 | 0.178 |
JAK3 |
0.538 | -0.148 | 1 | 0.169 |
TNK1 |
0.538 | -0.070 | 3 | 0.676 |
FGFR3 |
0.537 | -0.073 | 3 | 0.695 |
TNK2 |
0.537 | -0.083 | 3 | 0.633 |
TEK |
0.537 | -0.064 | 3 | 0.623 |
AXL |
0.537 | -0.132 | 3 | 0.694 |
EPHB1 |
0.537 | -0.152 | 1 | 0.171 |
EPHB3 |
0.537 | -0.136 | -1 | 0.472 |
DDR2 |
0.536 | -0.019 | 3 | 0.636 |
KDR |
0.536 | -0.111 | 3 | 0.669 |
NTRK3 |
0.536 | -0.100 | -1 | 0.472 |
SRC |
0.536 | -0.068 | -1 | 0.486 |
PDGFRB |
0.535 | -0.175 | 3 | 0.684 |
PTK6 |
0.535 | -0.150 | -1 | 0.445 |
BMX |
0.535 | -0.102 | -1 | 0.387 |
NTRK1 |
0.535 | -0.144 | -1 | 0.495 |
MET |
0.534 | -0.103 | 3 | 0.682 |
CK1G2 |
0.534 | -0.073 | -3 | 0.418 |
FLT3 |
0.534 | -0.159 | 3 | 0.661 |
PTK2B |
0.533 | -0.088 | -1 | 0.480 |
FGFR4 |
0.533 | -0.066 | -1 | 0.439 |
CSK |
0.532 | -0.054 | 2 | 0.548 |
PTK2 |
0.531 | -0.055 | -1 | 0.402 |
EPHA7 |
0.531 | -0.103 | 2 | 0.543 |
INSR |
0.531 | -0.114 | 3 | 0.635 |
TEC |
0.530 | -0.145 | -1 | 0.429 |
FLT1 |
0.530 | -0.145 | -1 | 0.444 |
SYK |
0.529 | -0.083 | -1 | 0.397 |
ALK |
0.529 | -0.152 | 3 | 0.612 |
PDGFRA |
0.529 | -0.171 | 3 | 0.671 |
EPHA8 |
0.528 | -0.094 | -1 | 0.436 |
EPHA5 |
0.528 | -0.111 | 2 | 0.539 |
LTK |
0.528 | -0.153 | 3 | 0.649 |
FLT4 |
0.528 | -0.142 | 3 | 0.678 |
ERBB2 |
0.527 | -0.155 | 1 | 0.160 |
LYN |
0.527 | -0.119 | 3 | 0.618 |
NTRK2 |
0.527 | -0.177 | 3 | 0.667 |
BTK |
0.527 | -0.195 | -1 | 0.445 |
MATK |
0.527 | -0.095 | -1 | 0.419 |
WEE1_TYR |
0.527 | -0.128 | -1 | 0.446 |
EPHA3 |
0.526 | -0.137 | 2 | 0.525 |
FRK |
0.526 | -0.140 | -1 | 0.468 |
ERBB4 |
0.525 | -0.072 | 1 | 0.154 |
EPHA1 |
0.523 | -0.152 | 3 | 0.660 |
IGF1R |
0.522 | -0.104 | 3 | 0.591 |
EPHA2 |
0.516 | -0.118 | -1 | 0.396 |
ZAP70 |
0.516 | -0.074 | -1 | 0.358 |
MUSK |
0.509 | -0.166 | 1 | 0.120 |
FES |
0.509 | -0.115 | -1 | 0.402 |